We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Collaboration Produces Clone of Endangered Species

By Biotechdaily staff writers
Posted on 16 Apr 2003
Three groups have combined their efforts to successfully clone a wild bovine species from the forests of Southeast Asia, closely related to the domesticated cow. More...
Two banteng clones were born to Angus cows in early April 2003.

The process began with the transfer of genetic material from the cell of one bovine species to another at a laboratory in Massachusetts operated by Advanced Cell Technology, Inc. (ACT, Worcester, USA). Scientists transferred the DNA of frozen banteng skin cells that had been stored in the San Diego (CA, USA) Frozen Zoo into empty eggs from ordinary domestic cows. The embryos were then transferred to the Trans Ova Genetics (Sioux Center, IA, USA) research center in Iowa, where they were implanted into ordinary cows, which gestated the calves.

"The Zoological Society of San Diego founded a genetic bank of frozen tissue samples, known as the Frozen Zoo, more than 25 years ago,” explained Oliver Ryder, Ph.D., geneticist for the society. "At that time, we did not know how this resource might be used, but we knew it was important to save as much information about endangered species as we could.”

Advanced Cell Technology is involved in the research and development of stem cells and therapeutic nuclear transfer technology for the treatment of human disease. Trans Ova Genetics is involved in the collection and nuclear transfer of bovine embryos. Cross-species cloning is a new procedure to be used in the effort to save endangered species and represents an application of genetic technology unavailable until a few years ago.





Related Links:
ACT
Trans Ova

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Urinalysis Solution
UN-9000
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.